Clin2
NCT07639866Possibly a fitNot yet recruiting

CXD plus keto diet for fatty liver

MASLD (Metabolic Dysfunction-Associated Steatotic Liver Disease)

Part of Digestive system, Hormones & metabolism clinical trials.

This study tests a combination of a traditional Chinese medicine treatment (CXD) and a special low-carb diet (ketogenic diet) to see if it can reduce fat in the liver for people with fatty liver disease (MASLD). It might help improve liver health.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 2
Enrollment
135 people
Ages
18 years to 50 years
Study type
Interventional

Who can take part

  • You are between 18 and 50 years old.
  • You have been diagnosed with a type of fatty liver disease called MASLD.
  • Your doctor confirms you have a 'dampness-heat accumulation' pattern based on Traditional Chinese Medicine.
  • A liver scan shows a certain level of fat in your liver (CAP score of 238 or higher).
  • Your body mass index (BMI) is 23 or higher.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07097506Recruiting· Phase 2
Ketone drink for liver fat and health

This study tests whether a daily ketone ester drink can reduce liver fat and improve metabolism in people with excess liver fat. You may join if you are 18–40, have overweight or obesity, and your liver has extra fat.

St Louis, Missouri
NCT07193927Recruiting· Phase 2
Testing a probiotic mix for fatty liver disease (MASLD)

This trial tests whether a probiotic mixture can improve liver health in people with moderate fatty liver disease (MASLD). It looks at how the probiotic affects liver fat, inflammation, and metabolism.

Girona, Girona
NCT04873258Recruiting
Test a non-invasive tool to screen for fat-related liver disease

This study looks at a new non-invasive screening method to predict metabolic dysfunction–associated steatotic liver disease (MASLD), a condition where fat builds up in the liver. The goal is to help identify people who may be at risk without needing invasive tests.

London, London
NCT07313007Recruiting
Gut bacteria chemicals in fatty liver disease

This study looks at whether the natural chemicals made by your gut bacteria from the food you eat could affect liver fat and health. If you have MASLD (a fatty liver condition), researchers want to measure these gut-produced substances to better understand the disease.

Pierre-Bénite
NCT06845345Enrolling by invitation· Phase 4
Can a special diet or pills help liver health?

This study compares two treatments for liver scarring in people with overweight or related health issues. One group follows a special diet with restricted eating times, while the other takes a combination of two medications (naltrexone and bupropion). It aims to see which approach better improves liver fibrosis.

Rotterdam
NCT06537466Not yet recruiting
Ketogenic diet for advanced liver scarring from fatty liver disease

This study tests whether a special high-fat, very low-carbohydrate diet (ketogenic) can help people with advanced liver scarring from fatty liver disease. It aims to see if this diet improves liver health without harmful side effects.

Palermo

Hear when a new MASLD (Metabolic Dysfunction-Associated Steatotic Liver Disease) trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.